Tumor-infiltrating lymphocyte activity is enhanced in tumors with low IL-10 production in HBV-induced hepatocellular carcinoma

Biochem Biophys Res Commun. 2015 May 22;461(1):109-14. doi: 10.1016/j.bbrc.2015.03.177. Epub 2015 Apr 8.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers and can be induced by chronic HBV infection. The role of HBV-specific immune responses in mediating tumorigenesis and HCC prognosis is debated. The effect of intratumoral microenvironment on tumor-infiltrating lymphocytes (TILs) is also unclear. Here, we examined resected tumor tissue from 36 patients with HBV-induced HCC. We categorized study cohort based on ex vivo IL-10 secretion by tumor cells into high IL-10-secreting (Hi10) and low IL-10-secreting (Lo10) groups, and found that the Lo10 group was less sensitive to TLR ligand stimulation. TILs from the Lo10 group contained higher frequencies of HBV-specific IFN-g-producing cells and total IFN-g-producing cells, and possessed higher proliferative capacity. Moreover, the proliferative capacity of TILs from the Hi10 group was negatively correlated with IL-10 secretion from tumor cells. Together, our data demonstrated that low IL-10-producing capacity in HBV-induced HCC tumors is associated with enhanced TIL activity.

Keywords: Hepatocellular carcinoma; IL-10; Tumor-infiltrating lymphocyte.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Hepatocellular / immunology*
  • Carcinoma, Hepatocellular / pathology*
  • Cell Proliferation
  • Cells, Cultured
  • Female
  • Hepatitis B / immunology*
  • Humans
  • Interleukin-10 / immunology*
  • Liver Neoplasms / immunology*
  • Liver Neoplasms / pathology*
  • Lymphocyte Activation / immunology
  • Lymphocytes / immunology*
  • Lymphocytes / pathology
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Tumor Microenvironment / immunology

Substances

  • IL10 protein, human
  • Interleukin-10